This inventor holds 4 USPTO granted patents and 1 published patent application and 4 EPO patents. Top assignee: Fujirebio Inc.. Active years: 2014-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014-2025
Title: Yoshiyuki Hotta: Innovator in Medical Testing
Introduction
Yoshiyuki Hotta is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of medical testing, particularly in the development of methods for analyzing blood for specific substances. With a total of 4 patents to his name, Hotta's work has the potential to enhance the accuracy and convenience of medical diagnostics.
Latest Patents
One of Hotta's latest patents is a method of testing blood for macrolide immunosuppressants. This invention provides a highly accurate and convenient approach to testing, which is crucial for patients undergoing treatment with these medications. Another notable patent involves a medium for mammalian somatic cells, which allows for effective growth of these cells while minimizing or eliminating the need for serum. This innovation is significant for research and therapeutic applications, as it improves the efficiency of cell culture processes.
Career Highlights
Yoshiyuki Hotta has established himself as a key figure in the medical research community. His work at Fujirebio Inc. has positioned him at the forefront of innovations in diagnostic testing. His contributions have not only advanced scientific knowledge but also have practical implications for patient care.
Collaborations
Hotta has collaborated with notable colleagues, including Masaya Toyonaga and Harumi Yamaguma. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the impact of their collective work.
Conclusion
Yoshiyuki Hotta's innovative contributions to medical testing exemplify the importance of research and development in healthcare. His patents reflect a commitment to improving diagnostic methods, ultimately benefiting patients and the medical community.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
